Sinopharm
1099.HK
#2254
Rank
โ‚น736.69 B
Marketcap
โ‚น236.07
Share price
1.09%
Change (1 day)
2.72%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

Revenue for Sinopharm (1099.HK)

Revenue in 2024: โ‚น7.228 Trillion

According to Sinopharm's latest financial reports the company's current revenue (TTM ) is โ‚น7.228 Trillion. In 2024 the company made a revenue of โ‚น7.228 Trillion a decrease over the revenue in the year 2023 that were of โ‚น7.617 Trillion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Sinopharm from 2006 to 2024

Annual revenue

Year Revenue Change
2024โ‚น7.228 T-5.1%
2023โ‚น7.617 T5.42%
2022โ‚น7.225 T-2.1%
2021โ‚น7.380 T16.85%
2020โ‚น6.315 T14.95%
2019โ‚น5.494 T21.52%
2018โ‚น4.521 T5.93%
2017โ‚น4.268 T27.22%
2016โ‚น3.354 T5.37%
2015โ‚น3.183 T9.14%
2014โ‚น2.917 T17.22%
2013โ‚น2.488 T25.94%
2012โ‚น1.975 T34.61%
2011โ‚น1.467 T55.34%
2010โ‚น944.97 B35.79%
2009โ‚น695.91 B37.56%
2008โ‚น505.91 B31.43%
2007โ‚น384.93 B40.26%
2006โ‚น274.44 B